PharmaCyte Biotech, Inc.: Form 8-K, filed Dec 30, 2022
Filed with the SEC on Dec 30, 2022 and accepted by EDGAR at Dec 30, 2022, 21:05 ET.
Items reported
- Item 5.07 Shareholder vote results
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001683168-22-008705. Last ingested by Listed: Oct 24, 2026, 15:05 ET. Listed shows no prices and gives no investment advice.